Moderna secures $56M for mobile vaccine manufacturing

By The Science Advisory Board staff writers

October 8, 2020 -- Moderna has received $56 million from the Defense Advanced Research Projects Agency (DARPA) to fund manufacturing of nucleic acid vaccines and therapeutics.

The award is part of DARPA's Nucleic Acids On-Demand World-Wide (NOW) initiative, the company said. The funding will help Moderna build on its current manufacturing capability by developing and implementing a 6 x 6 x 6-ft automated manufacturing unit that can be used around the world and can produce medicine doses quickly, the company said.

The award follows on a previous DARPA grant Moderna secured in 2013, according to the firm.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.